BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12544554)

  • 1. Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
    Sambamoorthi U; Olfson M; Walkup JT; Crystal S
    Med Care; 2003 Jan; 41(1):180-94. PubMed ID: 12544554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
    Griffiths RI; Sullivan EM; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    Pharmacoeconomics; 1999 May; 15(5):495-505. PubMed ID: 10537966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year costs of second-line therapies for depression.
    Sullivan EM; Griffiths RI; Frank RG; Strauss MJ; Herbert RJ; Clouse J; Goldman HH
    J Clin Psychiatry; 2000 Apr; 61(4):290-8. PubMed ID: 10830151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries.
    Sambamoorthi U; Ma Y; Findley PA; Rust G
    J Diabetes; 2013 Sep; 5(3):327-35. PubMed ID: 23173757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of depression in the elderly medicare population: predictors, disparities, and trends.
    Crystal S; Sambamoorthi U; Walkup JT; Akincigil A
    J Am Geriatr Soc; 2003 Dec; 51(12):1718-28. PubMed ID: 14687349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants.
    Frazer A
    J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
    [No Abstract]   [Full Text] [Related]  

  • 7. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical considerations for the treatment of depression in elderly and very elderly long-term care patients.
    Salzman C
    J Clin Psychiatry; 1999; 60 Suppl 20():30-3. PubMed ID: 10513856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments.
    Fairman KA; Teitelbaum F; Drevets WC; Engquist G; Kreisman JJ; Norusis MJ
    Am J Manag Care; 1997 Mar; 3(3):453-65. PubMed ID: 10169521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of antidepressant prescribing tendencies in Lithuania in 2003-2004.
    Jakimavicius M; Sveikata A; Vainauskas P; Jankūnas R; Mikucionyte L; Sapoliene A; Smigelskas K
    Medicina (Kaunas); 2007; 43(5):412-8. PubMed ID: 17563418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special Report from the CDC Antidepressant subclass use and fall risk in community-dwelling older Americans.
    Haddad YK; Luo F; Bergen G; Legha JK; Atherly A
    J Safety Res; 2021 Feb; 76():332-340. PubMed ID: 33653566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study.
    Monfared AA; Han D; Sheehy O; Bexton B; Lelorier J
    Curr Med Res Opin; 2006 Jan; 22(1):83-94. PubMed ID: 16393434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
    Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
    Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of eliminating drug caps on racial differences in antidepressant use among dual enrollees with diabetes and depression.
    Adams AS; Soumerai SB; Zhang F; Gilden D; Burns M; Huskamp HA; Trinacty C; Alegria M; LeCates RF; Griggs JJ; Ross-Degnan D; Madden JM
    Clin Ther; 2015 Mar; 37(3):597-609. PubMed ID: 25620439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.
    Qian J; Simoni-Wastila L; Langenberg P; Rattinger GB; Zuckerman IH; Lehmann S; Terrin M
    J Am Geriatr Soc; 2013 May; 61(5):754-61. PubMed ID: 23617752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sociological influences on antidepressant prescribing.
    Sleath B; Shih YC
    Soc Sci Med; 2003 Mar; 56(6):1335-44. PubMed ID: 12600369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining antidepressants for treatment-resistant depression: a review.
    Lam RW; Wan DD; Cohen NL; Kennedy SH
    J Clin Psychiatry; 2002 Aug; 63(8):685-93. PubMed ID: 12197448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W; Kucia K
    Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of antidepressant medications.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 4():4-11; discussion 12-3. PubMed ID: 10086478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.